Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 219 entries
Sorted by: Best Match Show Resources per page
Coupled Cluster Study of Photoionization and Photodetachment Cross Sections.

Journal of chemical theory and computation

Tenorio BN, Nascimento MA, Coriani S, Rocha AB.
PMID: 27434262
J Chem Theory Comput. 2016 Sep 13;12(9):4440-59. doi: 10.1021/acs.jctc.6b00524. Epub 2016 Aug 02.

No abstract available.

Cite
Tenorio BN, Nascimento MA, Coriani S, et al. Coupled Cluster Study of Photoionization and Photodetachment Cross Sections. J Chem Theory Comput. 2016;12(9):4440-59doi: 10.1021/acs.jctc.6b00524.
Tenorio, B. N., Nascimento, M. A., Coriani, S., & Rocha, A. B. (2016). Coupled Cluster Study of Photoionization and Photodetachment Cross Sections. Journal of chemical theory and computation, 12(9), 4440-59. https://doi.org/10.1021/acs.jctc.6b00524
Tenorio, Bruno Nunes Cabral, et al. "Coupled Cluster Study of Photoionization and Photodetachment Cross Sections." Journal of chemical theory and computation vol. 12,9 (2016): 4440-59. doi: https://doi.org/10.1021/acs.jctc.6b00524
Tenorio BN, Nascimento MA, Coriani S, Rocha AB. Coupled Cluster Study of Photoionization and Photodetachment Cross Sections. J Chem Theory Comput. 2016 Sep 13;12(9):4440-59. doi: 10.1021/acs.jctc.6b00524. Epub 2016 Aug 02. PMID: 27434262.
Copy Download .nbib Format: NLM
Chemotherapeutic Investigations with Antimony Preparations in the Experimental Kala-Azar of the Hamster.

The Indian medical gazette

Roehl W.
PMID: 29009723
Ind Med Gaz. 1929 Oct;64(10):563-564.

No abstract available.

Cite
Roehl W. Chemotherapeutic Investigations with Antimony Preparations in the Experimental Kala-Azar of the Hamster. Ind Med Gaz. 1929;64(10):563-564
Roehl, W. (1929). Chemotherapeutic Investigations with Antimony Preparations in the Experimental Kala-Azar of the Hamster. The Indian medical gazette, 64(10), 563-564.
Roehl, Wilhelm. "Chemotherapeutic Investigations with Antimony Preparations in the Experimental Kala-Azar of the Hamster." The Indian medical gazette vol. 64,10 (1929): 563-564.
Roehl W. Chemotherapeutic Investigations with Antimony Preparations in the Experimental Kala-Azar of the Hamster. Ind Med Gaz. 1929 Oct;64(10):563-564. PMID: 29009723; PMCID: PMC5164601.
Copy Download .nbib Format: NLM
Surface Termination Conversion during SrTiO3 Thin Film Growth Revealed by X-ray Photoelectron Spectroscopy.

Scientific reports

Baeumer C, Xu C, Gunkel F, Raab N, Heinen RA, Koehl A, Dittmann R.
PMID: 26189436
Sci Rep. 2015 Jul 20;5:11829. doi: 10.1038/srep11829.

Emerging electrical and magnetic properties of oxide interfaces are often dominated by the termination and stoichiometry of substrates and thin films, which depend critically on the growth conditions. Currently, these quantities have to be measured separately with different sophisticated...

Cite
Baeumer C, Xu C, Gunkel F, et al. Surface Termination Conversion during SrTiO3 Thin Film Growth Revealed by X-ray Photoelectron Spectroscopy. Sci Rep. 2015;5:11829doi: 10.1038/srep11829.
Baeumer, C., Xu, C., Gunkel, F., Raab, N., Heinen, R. A., Koehl, A., & Dittmann, R. (2015). Surface Termination Conversion during SrTiO3 Thin Film Growth Revealed by X-ray Photoelectron Spectroscopy. Scientific reports, 511829. https://doi.org/10.1038/srep11829
Baeumer, Christoph, et al. "Surface Termination Conversion during SrTiO3 Thin Film Growth Revealed by X-ray Photoelectron Spectroscopy." Scientific reports vol. 5 (2015): 11829. doi: https://doi.org/10.1038/srep11829
Baeumer C, Xu C, Gunkel F, Raab N, Heinen RA, Koehl A, Dittmann R. Surface Termination Conversion during SrTiO3 Thin Film Growth Revealed by X-ray Photoelectron Spectroscopy. Sci Rep. 2015 Jul 20;5:11829. doi: 10.1038/srep11829. PMID: 26189436; PMCID: PMC4507138.
Copy Download .nbib Format: NLM
A scaling theory for number-flux distributions generated during steady-state coagulation and settling and application to particles in Lake Zurich, Switzerland.

Journal of colloid and interface science

Boehm AB.
PMID: 12702397
J Colloid Interface Sci. 2002 Oct 15;254(2):266-73. doi: 10.1006/jcis.2002.8599.

In this study, we extend the established scaling theory for cluster size distributions generated during unsteady coagulation to number-flux distributions that arise during steady-state coagulation and settling in an unmixed water mass. The scaling theory predicts self-similar number-flux distributions...

Cite
Boehm AB. A scaling theory for number-flux distributions generated during steady-state coagulation and settling and application to particles in Lake Zurich, Switzerland. J Colloid Interface Sci. 2002;254(2):266-73doi: 10.1006/jcis.2002.8599.
Boehm, A. B. (2002). A scaling theory for number-flux distributions generated during steady-state coagulation and settling and application to particles in Lake Zurich, Switzerland. Journal of colloid and interface science, 254(2), 266-73. https://doi.org/10.1006/jcis.2002.8599
Boehm, Alexandria B. "A scaling theory for number-flux distributions generated during steady-state coagulation and settling and application to particles in Lake Zurich, Switzerland." Journal of colloid and interface science vol. 254,2 (2002): 266-73. doi: https://doi.org/10.1006/jcis.2002.8599
Boehm AB. A scaling theory for number-flux distributions generated during steady-state coagulation and settling and application to particles in Lake Zurich, Switzerland. J Colloid Interface Sci. 2002 Oct 15;254(2):266-73. doi: 10.1006/jcis.2002.8599. PMID: 12702397.
Copy Download .nbib Format: NLM
OH-stretch vibrational spectroscopy of hydroxymethyl hydroperoxide.

The journal of physical chemistry. A

Fry JL, Matthews J, Lane JR, Roehl CM, Sinha A, Kjaergaard HG, Wennberg PO.
PMID: 16737255
J Phys Chem A. 2006 Jun 08;110(22):7072-9. doi: 10.1021/jp0612127.

We report measurement and analysis of the photodissociation spectrum of hydroxymethyl hydroperoxide (HOCH(2)OOH) and its partially deuterated analogue, HOCD(2)OOH, in the OH-stretching region. Spectra are obtained by Fourier transform infrared spectroscopy in the 1nu(OH) and 2nu(OH) regions, and by...

Cite
Fry JL, Matthews J, Lane JR, et al. OH-stretch vibrational spectroscopy of hydroxymethyl hydroperoxide. J Phys Chem A. 2006;110(22):7072-9doi: 10.1021/jp0612127.
Fry, J. L., Matthews, J., Lane, J. R., Roehl, C. M., Sinha, A., Kjaergaard, H. G., & Wennberg, P. O. (2006). OH-stretch vibrational spectroscopy of hydroxymethyl hydroperoxide. The journal of physical chemistry. A, 110(22), 7072-9. https://doi.org/10.1021/jp0612127
Fry, Juliane L, et al. "OH-stretch vibrational spectroscopy of hydroxymethyl hydroperoxide." The journal of physical chemistry. A vol. 110,22 (2006): 7072-9. doi: https://doi.org/10.1021/jp0612127
Fry JL, Matthews J, Lane JR, Roehl CM, Sinha A, Kjaergaard HG, Wennberg PO. OH-stretch vibrational spectroscopy of hydroxymethyl hydroperoxide. J Phys Chem A. 2006 Jun 08;110(22):7072-9. doi: 10.1021/jp0612127. PMID: 16737255.
Copy Download .nbib Format: NLM
Therapeutic strategies for localized prostate cancer.

Reviews in urology

Lynch JH, Batuello JT, Crawford ED, Gomella LG, Kaufman J, Petrylak DP, Joel AB.
PMID: 16985999
Rev Urol. 2001;3:S39-48.

Prostate-specific antigen determinations for prostate cancer screening have led to a dramatic increase in the number of men who are diagnosed with organ-confined and therefore potentially curable prostate cancer. Advances in predicting outcomes with artificial neural networks may help...

Cite
Lynch JH, Batuello JT, Crawford ED, et al. Therapeutic strategies for localized prostate cancer. Rev Urol. 2001;3:S39-48
Lynch, J. H., Batuello, J. T., Crawford, E. D., Gomella, L. G., Kaufman, J., Petrylak, D. P., & Joel, A. B. (2001). Therapeutic strategies for localized prostate cancer. Reviews in urology, 3S39-48.
Lynch, J H, et al. "Therapeutic strategies for localized prostate cancer." Reviews in urology vol. 3 (2001): S39-48.
Lynch JH, Batuello JT, Crawford ED, Gomella LG, Kaufman J, Petrylak DP, Joel AB. Therapeutic strategies for localized prostate cancer. Rev Urol. 2001;3:S39-48. PMID: 16985999; PMCID: PMC1476072.
Copy Download .nbib Format: NLM
US expert warns interdependence of countries makes world more vulnerable to flu pandemic.

BMJ (Clinical research ed.)

Roehr B.
PMID: 17289713
BMJ. 2007 Feb 10;334(7588):281. doi: 10.1136/bmj.39118.367523.DB.

No abstract available.

Cite
Roehr B. US expert warns interdependence of countries makes world more vulnerable to flu pandemic. BMJ. 2007;334(7588):281doi: 10.1136/bmj.39118.367523.DB.
Roehr, B. (2007). US expert warns interdependence of countries makes world more vulnerable to flu pandemic. BMJ (Clinical research ed.), 334(7588), 281. https://doi.org/10.1136/bmj.39118.367523.DB
Roehr, Bob. "US expert warns interdependence of countries makes world more vulnerable to flu pandemic." BMJ (Clinical research ed.) vol. 334,7588 (2007): 281. doi: https://doi.org/10.1136/bmj.39118.367523.DB
Roehr B. US expert warns interdependence of countries makes world more vulnerable to flu pandemic. BMJ. 2007 Feb 10;334(7588):281. doi: 10.1136/bmj.39118.367523.DB. PMID: 17289713; PMCID: PMC1796705.
Copy Download .nbib Format: NLM
US primary care must reorient to prevention to cut costs and improve outcomes.

BMJ (Clinical research ed.)

Roehr B.
PMID: 21159769
BMJ. 2010 Dec 15;341:c7226. doi: 10.1136/bmj.c7226.

No abstract available.

Cite
Roehr B. US primary care must reorient to prevention to cut costs and improve outcomes. BMJ. 2010;341:c7226doi: 10.1136/bmj.c7226.
Roehr, B. (2010). US primary care must reorient to prevention to cut costs and improve outcomes. BMJ (Clinical research ed.), 341c7226. https://doi.org/10.1136/bmj.c7226
Roehr, Bob. "US primary care must reorient to prevention to cut costs and improve outcomes." BMJ (Clinical research ed.) vol. 341 (2010): c7226. doi: https://doi.org/10.1136/bmj.c7226
Roehr B. US primary care must reorient to prevention to cut costs and improve outcomes. BMJ. 2010 Dec 15;341:c7226. doi: 10.1136/bmj.c7226. PMID: 21159769.
Copy Download .nbib Format: NLM
Institute urges overhaul of US cancer trials network.

BMJ (Clinical research ed.)

Roehr B.
PMID: 20410175
BMJ. 2010 Apr 21;340:c2142. doi: 10.1136/bmj.c2142.

No abstract available.

Cite
Roehr B. Institute urges overhaul of US cancer trials network. BMJ. 2010;340:c2142doi: 10.1136/bmj.c2142.
Roehr, B. (2010). Institute urges overhaul of US cancer trials network. BMJ (Clinical research ed.), 340c2142. https://doi.org/10.1136/bmj.c2142
Roehr, Bob. "Institute urges overhaul of US cancer trials network." BMJ (Clinical research ed.) vol. 340 (2010): c2142. doi: https://doi.org/10.1136/bmj.c2142
Roehr B. Institute urges overhaul of US cancer trials network. BMJ. 2010 Apr 21;340:c2142. doi: 10.1136/bmj.c2142. PMID: 20410175.
Copy Download .nbib Format: NLM
Data in trials and their published papers do not always agree, finds analysis.

BMJ (Clinical research ed.)

Roehr B.
PMID: 23390259
BMJ. 2013 Feb 06;346:f809. doi: 10.1136/bmj.f809.

No abstract available.

Cite
Roehr B. Data in trials and their published papers do not always agree, finds analysis. BMJ. 2013;346:f809doi: 10.1136/bmj.f809.
Roehr, B. (2013). Data in trials and their published papers do not always agree, finds analysis. BMJ (Clinical research ed.), 346f809. https://doi.org/10.1136/bmj.f809
Roehr, Bob. "Data in trials and their published papers do not always agree, finds analysis." BMJ (Clinical research ed.) vol. 346 (2013): f809. doi: https://doi.org/10.1136/bmj.f809
Roehr B. Data in trials and their published papers do not always agree, finds analysis. BMJ. 2013 Feb 06;346:f809. doi: 10.1136/bmj.f809. PMID: 23390259.
Copy Download .nbib Format: NLM
Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect.

Frontiers in neuroenergetics

Rodell AB, Aanerud J, Braendgaard H, Gjedde A.
PMID: 22783187
Front Neuroenergetics. 2012 Jul 05;4:8. doi: 10.3389/fnene.2012.00008. eCollection 2012.

We tested the claim that inter-individual CBF variability in Alzheimer's disease (AD) is substantially reduced after correction for arterial carbon dioxide tension (PaCO(2)). Specifically, we tested whether the variability of CBF in brain of patients with AD differed significantly...

Cite
Rodell AB, Aanerud J, Braendgaard H, et al. Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect. Front Neuroenergetics. 2012;4:8doi: 10.3389/fnene.2012.00008.
Rodell, A. B., Aanerud, J., Braendgaard, H., & Gjedde, A. (2012). Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect. Frontiers in neuroenergetics, 48. https://doi.org/10.3389/fnene.2012.00008
Rodell, Anders Bertil, et al. "Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect." Frontiers in neuroenergetics vol. 4 (2012): 8. doi: https://doi.org/10.3389/fnene.2012.00008
Rodell AB, Aanerud J, Braendgaard H, Gjedde A. Low Residual CBF Variability in Alzheimer's Disease after Correction for CO(2) Effect. Front Neuroenergetics. 2012 Jul 05;4:8. doi: 10.3389/fnene.2012.00008. eCollection 2012. PMID: 22783187; PMCID: PMC3389721.
Copy Download .nbib Format: NLM
Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain.

Frontiers in neuroenergetics

Gejl M, Lerche S, Egefjord L, Brock B, Møller N, Vang K, Rodell AB, Bibby BM, Holst JJ, Rungby J, Gjedde A.
PMID: 23543638
Front Neuroenergetics. 2013 Mar 27;5:2. doi: 10.3389/fnene.2013.00002. eCollection 2013.

In hyperglycemia, glucagon-like peptide-1 (GLP-1) lowers brain glucose concentration together with increased net blood-brain clearance and brain metabolism, but it is not known whether this effect depends on the prevailing plasma glucose (PG) concentration. In hypoglycemia, glucose depletion potentially...

Cite
Gejl M, Lerche S, Egefjord L, et al. Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain. Front Neuroenergetics. 2013;5:2doi: 10.3389/fnene.2013.00002.
Gejl, M., Lerche, S., Egefjord, L., Brock, B., Møller, N., Vang, K., Rodell, A. B., Bibby, B. M., Holst, J. J., Rungby, J., & Gjedde, A. (2013). Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain. Frontiers in neuroenergetics, 52. https://doi.org/10.3389/fnene.2013.00002
Gejl, Michael, et al. "Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain." Frontiers in neuroenergetics vol. 5 (2013): 2. doi: https://doi.org/10.3389/fnene.2013.00002
Gejl M, Lerche S, Egefjord L, Brock B, Møller N, Vang K, Rodell AB, Bibby BM, Holst JJ, Rungby J, Gjedde A. Glucagon-like peptide-1 (GLP-1) raises blood-brain glucose transfer capacity and hexokinase activity in human brain. Front Neuroenergetics. 2013 Mar 27;5:2. doi: 10.3389/fnene.2013.00002. eCollection 2013. PMID: 23543638; PMCID: PMC3608902.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 219 entries